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Sllmmary 
Allografts of the liver, which has a comparatively heavy leukocyte content compared with other 
vascularized organs, are accepted permanently across major histocompatibility complex barriers 
in many murine strain combinations without immunosuppressive  therapy. It has been postulated 
that this inherent tolerogenicity of the liver may be a consequence of the migration and perpetua- 
tion within host lymphoid tissues of potentially tolerogenic donor-derived ("chimeric") leuko- 
cytes, in particular, the precursors  of chimeric dendritic cells (DC). In this study, we have used 
granulocyte/macrophage  colony-stimulating  factor to induce the propagation of progenitors that 
give rise to DC (CD45 +, CDllc +  , 33D1 +, nonlymphoid dendritic cell 145 +, major histocom- 
patibility complex class II +, B7-1 +) in li~tuid cultures of murine bone marrow cells. Using this 
technique, together with immunocytochemical and molecular methods, we show that, in addi- 
tion to cells expressing female host  (C3H) phenotype (H-2Kk+;  I-E+;  Y  chromosome-), a 
minor population of male donor (B10)-derived cells (H-2Kb+; I-A+; Y chromosome  +) can also 
be grown in 10-d DC cultures from the bone marrow of liver allograft recipients 14 d after 
transplant.  Highly  purified nonlymphoid dendritic cell  145 +  DC  sorted  from  these bone 
marrow-derived cell  cultures  were  shown to  comprise ~1-10%  cells  of donor  origin  (Y 
chromosome  +) by polymerase chain reaction analysis. In addition, sorted DC stimulated naive, 
recipient strain T lymphocytes in primary mixed leukocyte cultures. Evidence was also obtained 
for the growth of donor-derived cells from the spleen but not the thymus. In contrast, donor 
ceils could not be propagated from the bone marrow or other lymphoid tissues of nonimmunosup- 
pressed C3H mice rejecting cardiac allografrs from the same donor strain (B10). These findings 
provide a basis for the establishment and perpetuation of cell chimerism after organ transplantation. 
n  unresolved enigma with  the  recent  demonstration 
of persistent low-level donor leukocyte chimerism after 
organ transplantation (1-4) has been the means by which the 
chimeric cells can be perpetuated up to many years (2) postoper- 
atively. Both in rodents (5-7) and in humans (8), dendritic 
cells (DC), 1 which have well-recognized in vivo migratory 
ability (9-12), feature prominently in immunohistochemical 
analyses of this multilineage chimerism in long-term successful 
organ recipients.  For some time, it has been recognized that 
DC in lymphoid and other organs arise from proliferating 
bone marrow--derived precursors (13-15). Only recently, how- 
1 Abbreviations used in this paper: DC, dendritic  cells; NPC, liver nonparen- 
chymal cells; OLTx, orthotopic  liver transplantation. 
ever, have in vitro systems been developed for inducing the 
growth of these cells from precursors present in either the 
blood (16) or bone marrow (17). Similar methods have con- 
firmed the presence of DC progenitors within the spleen (18) 
or liver (19). In each of these systems, liquid culture has been 
used to generate DC under the aegis of GM-CSF.  This ap- 
proach has permitted extensive characterization of the progeny 
DC, including their structural features, motility, immuno- 
phenotype, aUostimulatory activity, and in vivo homing ability. 
With respect to murine liver-derived DC progenitors, it has 
been shown that their injection into nonimmunosuppressed 
allogeneic  recipients gives rise to strongly MHC class II- 
positive cells that persist for months within T-dependent areas 
of secondary lymphoid tissue (20). 
In mice, liver but not other organ allografts  are accepted 
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combinations, without the requirement for immunosuppres- 
sion (6).  Here we present evidence that liver allografts ex- 
port DC precursors that can be propagated in GM-CSF from 
the bone marrow or spleen of unmodified recipients.  This 
novel finding, together with failure to propagate donor cells 
from the lymphoid tissues  of nonimmunosuppressed  mice 
rejecting cardiac allografts from the same donor strain, is con- 
gruent with the possibility that bidirectional leukocyte migra- 
tion and donor cell chimerism play key roles in organ graft 
acceptance and  acquired transplantation  tolerance. 
Materials and Methods 
Animals.  10-12-wk-old  male  C57BL/10J  mice  (B10; H-28, 
I-A b, I-E-) and C3H/HeJ (C3H; H-2  k, I-A  k, I-E  k) mice of both 
sexes were purchased from The Jackson Laboratory (Bar Harbor, 
ME). They were maintained in the specific pathogen-free facility 
of the University of Pittsburgh Medical Center (Pittsburgh, PA). 
Liver and Heart Transplantation.  Orthotopic liver transplanta- 
tion (OLTx) was performed in a mouse strain combination (B10 
to C3H; MHC class I, II and multiple non-MHC antigen dispari- 
ties) with a high liver acceptance rate (6), using techniques described 
previously (21) with minor modifications. Briefly, after damping 
the artery and portal vein, the donor liver was flushed thoroughly 
via the portal vein with cold lactated Ringer's solution. A supra- 
hepatic vena cava anastomosis was completed, with a 10-0 running 
suture. The cuff technique was used for anastomosis of both the 
intrahepatic vena cava and the portal vein. No attempt was made 
to reconstruct the graft arterial supply.  The bile ducts were an- 
nealed by inserting a polyethylene tube into both. Blood lost during 
the operation was replaced with lactated Ringer's solution. The 
method for heterotopic heart transplantation was adapted from the 
rat procedure of Ono and Lindsey (22). The heart was transplanted 
into the abdomen with end to side anastomosis of aorta to aorta 
and pulmonary artery to vena cava. Rejection was defined by the 
cessation of cardiac contraction after daily palpation through the 
abdominal wall, and it was confirmed by histological examination. 
No immunosuppressive therapy was used in either procedure, and 
the animals (three per group in each experiment) were killed 14 d 
after OLTx or 8 d  after heart transplantation. 
Isolation of Leukocytes  from Tissues.  Before harvesting of organs 
from transplanted animals,  whole body perfusion was performed 
to minimize blood contamination of tissues. 30 ml HBSS (GIBCO 
BRL, Gaithersburg, MD) was infused over a 3-min period via the 
inferior vena cava. Bone marrow cell suspensions  and mononuclear 
cells from the  spleen  or thymus were prepared in  RPMI  1640 
(GIBCO BILL) using conventional methods. Liver nonparenchymal 
cells (NPC) (<5% hepatocyte contamination) were isolated as de- 
scribed in detail elsewhere (19). Briefly, the liver was perfused in 
situ via the portal vein with collagenase solution (type IV, 1 mg/ml 
in HBSS; Sigma Chemical Co., St. Louis,  MO).  It was then re- 
moved, diced, and further digested with collagenase in vitro. The 
washed cells were then centrifuged on Percoll (Sigma Chemical 
Co.) gradients, and the leukocyte-rich layer was harvested as de- 
scribed  (19). 
Culture of Tissue-derived Cells with GM-CSE  1-2  x  106 cells 
obtained from the bone marrow, spleen, thymus, or liver were cul- 
tured per well in 24-well plates in 2 ml RPMI 1640, supplemented 
with 10% FCS and 0.4 ng/ml mouse rGM-CSF (R&D Systems, 
Minneapolis, MN).  In some experiments, bone marrow-derived 
cells were cultured in GM-CSF (4 ng/ml) plus IL-4 (1,000 U/ml) 
(each cytokine was from Schering-Plough, Kenilworth, NJ) in an 
effort to maximize the development of their allostimulatory ac- 
tivity (23). The procedure used was similar  to that described ini- 
tially by Inaba et al. (17) for the propagation of large numbers of 
DC from mouse bone marrow. The medium containing GM-CSF 
(or GM-CSF plus IIA) was refreshed every 2 d; after gentle swirling 
of the plates, half of the old medium was aspirated and an equiva- 
lent volume of fresh cytokine-supphmented medium added.  This 
method was  implemented to deplete nonadherent  granulocytes 
without dislodging clusters of developing DC that attached loosely 
to a monolayer of firmly plastic-adherent macrophages. Morpho- 
logical  and phenotypic analyses of typical,  single,  nonadherent 
mononuclear cells released spontaneously from the clusters were 
performed after 10 d. 
Staining of Cell Surface and Intracellular Antigens.  Cell surface 
staining was analyzed by cytofluorography using a FACScan  |  flow 
cytometer (Becton Dickinson & Co., Mountain View, CA). Staining 
with primary hamster or rat mAbs,  including rat anti-B7-1 and 
-B7-2  (Pharmingen,  San  Diego,  CA)  was  followed by FITC- 
conjugated goat anti-hamster or mouse anti-rat Igs as described 
(18, 19). Donor and recipient MHC class I- and class II-positive 
calls were identified using biotin-conjugated mouse anti-mouse 
mAbs  (Pharmingen,  San  Diego,  CA)  with  FITC  streptavidin 
(Jackson ImmunoResearch Laboratories,  Inc., West Grove, PA) as 
the secondary reagent. After staining,  the ceils were fixed in 1% 
paraformaldehyde in saline before analysis, mAbs to MHC class 
II antigens and to the 2A1 DC-restricted granule antigen were 
tested on cytospin preparations as described (17, 18). The speci- 
mens were fixed in acetone and stained  with biotinylated mouse 
anti-MHC class II or rat anti-2A1 mAbs, followed by streptavidin 
biotin peroxidase complex (ABC-P; Boehringer Mannheim Corp., 
Indianapolis, IN) or peroxidase-conjugated  anti-rat Ig, respectively. 
The nuclei were counterstained with hematoxylin. 
Detection of  Donor Male (Y) Chromosome in Cell Cultures by PCR 
Analysis.  DNA was prepared from freshly isolated and 10-d GM- 
CSF-stimulated cells from both normal male B10 and female C3H 
mice and from female C3H mice 14 or 8 d, respectively, after liver 
or heart transplantation from male B10 donors. The presence  of 
male donor cells was determined as previously described for human 
analysis (24) by PCR amplification of the SRY region of the mouse 
Y  chromosome. Primers  (5'-CAGCCCTACAGCCACAT-3'  and 
5'-CCACTCCTCTGTGACACTTT-3')  were  chosen  from  the 
p4.2.2 sequence (25). 1-/zg aliquots of DNA were amplified with 
30 cycles at 94~  for 30 s, 55~  for 30 s, and 72~  for 30 s in 
buffer consisting of 50 mM KC1, 10 mM Tris-HC1, pH 8.3,  1.5 
mM MgC12, 0.2 mM deoxynucleotides, 0.1%  gelatin,  0.2 #M 
primers, and 2.5 U of Taq polymerase (Perkin-Elmer Corp., Nor- 
walk, CT). The products were separated in a 1% agarose gel, trans- 
ferred to nylon membrane, and hybridized with an identical purified 
and radiolabeled 32p PCR product from male mouse DNA. Single- 
copy sensitivity and male specificity  were verified with control 
samples consisting of serial dilutions of male mouse DNA into that 
of female  mouse DNA. 
Sorting of DC.  Before  staining  with  mAb,  cultured  bone 
marrow-derived cells were incubated with 10% goat serum (Vector 
Laboratories,  Inc., Burlingame, CA) in HBSS (GIBCO BRL) at 
4~  for 30 min to eliminate nonspecific binding. The cells were 
then washed once in HBSS containing 0.1% BSA (Sigma Chem- 
ical Co.) and resuspended to a concentration of 40  x  106 ml in 
the same buffer. A saturating concentration of nonlymphoid den- 
dritic cells [NLDC] 145 mAb (a gift from Dr. R. M. Steinman, 
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trol (Sigma Chemical Co.) was added, and cells were incubated 
for 45 min at 4oC. After two washes  in HBSS, the cells  were stained 
with FITC-conjugated goat anti-rat IgG (Sigma Chemical Co.) 
under the same conditions. They were then washed and resuspended 
in complete KPMI 1640 medium supplemented with 2%  FCS 
(GIBCO BRL) for cell sorting.  NLDC 145 + and NLDC 145- 
cells were sorted into distinct cell populations based on forward 
scatter, side scatter, and FITC fluorescence  intensity using a FAC- 
Star Plus  |  cell sorter (Becton Dickinson & Co.). Cells were excited 
with a 5-mW argon/HeNe laser (Coherent Inc., Palo Alto, CA) 
attaining purities of both populations >90%. 
Mixed Leukocyte Cultures.  To test the allostimulatory activity 
of cultured, bone marrow-derived cells, one-way mixed leukocyte 
cultures (2  x  1@ responder cells per well in 96-well, round-bottom 
microculture plates) were performed. Various numbers of 3~-irradi- 
ated (20 Gy) stimulator cells propagated with GM-CSF plus I1.4 
from donor (B10) or recipient (C3H) strain animals or from the 
bone marrow of liver aUograft recipients were added. As an aid 
to determining the incidence of donor-derived allostimulatory cells 
propagated from graft recipients, "artificial" mixtures of cultured 
donor (1-10%) and recipient strain bone marrow-derived cells were 
also used as stimulators.  C3H or B10 spleen cells were used as 
responders, which were T cell enriched by sequential removal of 
plastic adherent cells (1 h at 370C) and by passage (1 h) through 
a nylon wool column. Cultures were maintained in RPMI 1640 
complete medium supplemented with 10% heat-inactivated FCS 
for 72 h in 5% CO2 in air; for the final 18 h,  10 #1 [3H]TdR. 
(1 #Ci) was added to each well. Cells were harvested onto glass 
fiber disks using a multiple cell harvester, and the degree of thymi- 
dine incorporation was determined in a liquid scintillation counter. 
Results were expressed as mean cpm  _+  1 SD. 
Results 
Propagation of DC from Normal Mouse Bone Marrow.  In 
prior studies, aggregates of growing DC progenitors were 
described in cultures established from mouse liver or spleen 
cell suspensions (18, 19) using procedures modified after Inaba 
and co-workers (16, 17). Similar techniques were adopted to 
propagate DC progenitors from the bone marrow of B10 and 
C3H mice. At 2 and 4 d of culture, non- or loosely adherent 
granulocytes were removed, without dislodging clusters of 
developing DC that were attached to firmly plastic-adherent 
macrophages.  After  day  4,  granulocytes were  no  longer 
significant contaminants, and the cultures were maintained 
routinely for 10 d. Numerous dendritic-shaped cells appeared 
to be released from the clusters. These floating cells exhibited 
typical dendritic projections and other structural features of 
DC (17,  19,  26)  upon light microscopic examination. 
Immunophenotypic Analysis of GM-CSF-stimulated Bone Mar- 
row-derived Cells.  To ascertain the surface phenotype of cells 
released from proliferating aggregates, flow cytometric analysis 
was performed after 10 d  of culture in GM-CSF.  Staining 
for  cells  of  lymphoid  lineage  (CD3 +,  CD4 +,  CD8 +, 
B220 +)  including  NK  cells  (NKI.1 +)  was  absent.  The 
floating cells in 10-d bone marrow-derived cultures expressed 
surface antigens that are known to be associated with mu- 
fine DC. These included CD45 (leukocyte common antigen), 
MHC class I, heat-stable antigen (J11D), CD54 (intercellular 
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adhesion molecule-I), CD11b (membrane attack complex-I), 
and CD44  (nonpolymeric determinant of Pgp.1  glycopro- 
tein). In addition, staining of moderate intensity was observed 
for the routine DC-restricted markers NLDC  145  (inter- 
digitating cells), 33D1, and CD11c (N418; B2-integrin); for 
the macrophage antigen F4/80; and for Fc3'RII, as described 
previously (17) for bone marrow-derived DC. The cells also 
expressed moderate levels of MHC class II and of the costimula- 
tory molecule and CD28 ligand, B7-1. The cells were nega- 
tive, however, for cell surface expression of the CD28 coligand 
B7-2.  Expression of the low affinity IIr  receptor (CD25) 
could also  not be demonstrated (data not shown). 
Cytospins were prepared to further characterize the released 
DC. By day 10, the majority of the cells were dendritic by 
Giemsa stain and expressed high levels of MHC class II. Gran- 
ulocytcs were rare. The majority of the cells  strongly ex- 
pressed the DC-restricted granule antigen 2A1 (17, 18). Similar 
results were obtained whether the cultures were established 
from cells obtained from the bone marrow of either B10 or 
C3H mice. 
Detection of Cells Expressing Donor Phenotype in Freshly Iso- 
lated Bone Marrow  from Liver Allografi Recipients.  C3H mice 
accept livers from B10 donors spontaneously, with graft sur- 
vival times consistently >100 d (6). To identify cells expressing 
donor phenotype in freshly isolated bone marrow cell suspen- 
sions obtained from nonimmunosuppressed C3H mice 14 d 
after OLTx from B10 donors, mAbs directed against donor 
(H-2  b) and recipient (H-2  k) MHC class I antigens were used. 
Typically, as shown in Fig. 1 (left), the incidence of cells ex- 
pressing donor MHC class I determined by flow cytometry 
in allografted mice was very low ('-1%),  whereas that of 
recipient was, as expected, consistently very high (>84%). 
Cells Expressing Donor Phenotype in Bone Marrow DC Cul- 
tures from Liver Allografi Recipients.  We next determined 
whether DC expressing donor cell surface phenotype could 
be propagated using GM-CSF from postulated small num- 
bers of progenitor cells in freshly isolated bone marrow of 
unmodified liver allograft recipients.  As  shown in Fig.  1 
(right), both cells expressing recipient (H-2K  k+) and those 
expressing donor MHC class I (H-2K  b+) could be identified 
by cytofluorometry  in 10-d cultures propagated using the same 
methods as for DC from normal bone marrow. Staining of 
cytospins for recipient and donor MHC  class  II products 
confirmed the presence of small numbers of donor (I-A  b+) 
cells (Fig. 2). In several repeat experiments using pooled bone 
marrow cells from groups of three allograft recipients, the 
incidence of donor MHC class II + cells in 10-d GM-CSF- 
stimulated cultures ranged from 5  to  17%. 
Detection of Donor Y  Chromosome in GM-CSF-stimulated 
Cultures from Liver Allografi Recipients.  The apparent inci- 
dence of donor-derived DC  in GM-CSF-stimulated bone 
marrow cell cultures was comparatively low. Therefore, to 
eliminate the possibility of false positive results due to min- 
imal antibody cross-reactivity or to the uptake of donor MHC 
products by recipient APC, PCR analysis for donor Y chro- 
mosome was performed on cells cultured from female (C3H) 
recipients of male (B10) liver grafts killed 14 d  after trans- 
plant.  Detection of Y chromosome (Fig.  3) confirmed the BONE MARROW: MHC CLASS 1 
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Figure  1.  Flow cytometric analyses (MHC  class I 
staining) of freshly  isolated  (left) and GM-CSF-stimulated 
bone marrow DC  (right) from  normal B10  (H-2b), 
normal C3H (H-2~), and unmodified  B10 --- C3H ortho- 
topic liver  allograft  recipients 14 d after  transplant. Donor 
strain (B10) and recipient strain cells (C3H) are identified 
by staining  for H-2K  b and H-2K  k, respectively.  Cultured 
cells were maintained  for 10 d before analysis. Note the 
coexistence  of cells expressing donor class I (H-2K  b line; 
arrowed) and recipient  class I in the DC cultures  propagated 
from transplanted  mice (bottom right). The result is repre- 
sentative of three separate experiments. 
growth of donor-derived cells in the 10-d bone marrow cell 
cultures and reinforced the immunocytochemical observations. 
Y  chromosome signal was also detected in  10-d spleen cell 
cultures and was also increased in magnitude compared with 
freshly isolated cells.  The signal, however, was substantially 
lower compared with bone marrow-derived  cells  (Fig.  3), 
indicating that comparatively few donor-derived, GM-CSF- 
responsive DC precursors had reached the spleen. A  dimin- 
ished signal for donor (male) cells in 10-d GM-CSF-stimu- 
lated liver-derived cell populations  (Fig.  3)  may reflect the 
deliberate physical removal and also the death of contaminating 
male hepatocytes (<5%  at the initiation of the cultures). In 
addition, in situ replacement of donor (male) with host (fe- 
male) GM-CSF-responsive cells within the liver by day 14 
after transplant (5, 6), when the cells were freshly isolated, 
may contribute to the relative reduction in the donor signal 
from cultured liver-derived cells on day 10.  In contrast  to 
bone marrow and spleen,  and despite histological findings 
(5) and evidence for chimerism in freshly isolated thymus cell 
suspensions,  no signal for donor-derived cells  could be de- 
tected in  10-d GM-CSF-stimulated cultures of thymocytes 
from liver allograft recipients. This suggested that, although 
a site in which chimeric cells  are detected after OLTx, the 
thymus may not be a destination for adequate numbers of 
donor-derived immature DC  progenitors. 
Evidence that the Donor-derived Cells are DC.  We next sought 
direct evidence that the donor-derived cells propagated from 
the bone marrow of liver allograft recipients were DC. Sorting 
Figure 2.  Coexistence  of cells expressing  donor (H-2b; I-A  b) 
and recipient strain (H-2k; I-E  ~) MHC class II phenotype  in 10-d 
cultures of GM-CSF-stimulated  cells propagated  from the bone 
marrow of liver-allografted [B10 (H-2  b) ~  C3H (H-2t)] mice 
killed 14 d after transplant. Staining was performed using the 
appropriate biotinylated mouse anti-mouse mAb, followed  by 
streptavidin biotin peroxidase  complex, as described (19). (a) Ig 
isotype control; (b) evidence  of occasional  donor (I-A  b+) cells; 
as well as (c) DC expressing  recipient phenotype  (I-E~+). Coun- 
terstained with hematoxylin, x250. 
382  Growth of Donor-derived Dendritic Cells from Allograft Recipients Figure 3.  Detection  of the donor Y chromosome  in cells  cultured  from 
female recipients of male livers killed 14 d after OLTx. PCR analysis  was 
performed  on freshly  isolated  (day  0) and day 10 GM-CSF-stimulated  bone 
marrow, liver NPC, spleen, or thymus cultures. There is convincing  evi- 
dence of growth of donor-derived  cells from the bone marrow and also 
the spleen, while no male  cells  appear  to have  propagated  from the thymus. 
Survival  of  donor liver-derived  cells  is also  evident  (for  discussion,  see text). 
Similar  results  were obtained  in three separate  experiments  using cells  pooled 
from three transplanted mice. 
of donor-positive cells was considered, but  the anticipated 
yield of cells was calculated to be  too low for subsequent 
functional analysis. Instead, 10-d GM-CSF-stimulated, bone 
marrow-derived cells were harvested, and NLDC 145 § cells 
were  sorted  (at  least  90%  purity  by  morphologic  and 
FACScan  |  analysis;  Fig.  4,  a  and  b)  and then investigated 
for the presence of donor Y chromosome. As shown in Fig. 
4 c, the results of PCR analyses demonstrated convincingly 
that the highly purified DC population comprised '~1-10% 
Y  chromosome-positive  (donor-derived)  cells.  Further evi- 
dence for the presence  of donor-derived DC  was obtained 
by  testing  the  allostimulatory  activity  of sorted,  NLDC 
145 + GM-CSF plus IL-4-stimulated, bone marrow-derived 
cells in primary MLR. As shown in Fig. 5 A,  the purified 
NLDC 145 + population propagated from C3H recipients of 
B10 allografts strongly stimulated B10 responders but also 
stimulated a response in recipient strain T  cells (Fig. 5 B). 
The extent of stimulation (P <0.01 compared with negatively 
sorted cells or syngeneic DC)  was  similar to that achieved 
with "artificial mixtures" containing 1%  donor strain DC. 
Failure to Propagate Donor-derived Cells from Bone Marrow 
of  Mice Rejecting Heart Allografts.  In contrast to liver allograft 
recipients, nonimmunosuppressed C3H mice reject heart al- 
log,  rafts from the same donor strain  (B10)  within 8  d  (6). 
PCR analysis for donor Y  chromosome was performed on 
10-d GM-CSF-stimulated cultures of bone marrow cells har- 
vested from heterotopic cardiac allograft recipients 8 d after 
transplant. In contrast to the results obtained from liver graft 
recipients, no evidence was obtained for the propagation of 
donor-derived cells from the bone marrow of animals rejecting 
their cardiac grafts (Fig. 6), despite evidence of chimeric cells 
in freshly isolated bone marrow.  It thus appears that these 
heart-derived cells, in contrast to those detected in fresh bone 
marrow of liver allograft recipients, do not comprise sufficient 
numbers of GM-CSF-responsive progenitors to allow growth 
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Figure 4.  Demonstration that donor-derived  cells in 10-d GM-CSF- 
stimulated  bone marrow cell cultures  from liver-allografted  mice are DC. 
(a) FACScan  |  profile  of sorted NLDC 145 + cells  from GM-CSF-stimu- 
lated bone marrow (day 10) reanalyzed  from purity of the sorted popula- 
tion. Horizontal  bars indicate  (I) limits of range of  negatively  sorted  cells; 
and (2) sorted NLDC 145 + cells (>90% purity). (b) Cytospin prepara- 
tion showing  the dendritic  morphology  of the sorted NLDC 145 § popu- 
lation x 250. (c) PCR analysis  of pre- and postsorted cells, showing the 
presence of donor-derived Y chromosome  in the NLDC 145+ fraction. 
of donor-derived cells (as opposed to amplification in the case 
of liver grafts)  after  10  d  of culture. 
Discussion 
In  a previous  search  for myeloid progenitors  in normal 
mouse liver using the same methods subsequently adopted 
in this study, ceils were propagated with GM-CSF that ex- 
hibited many characteristics of DC (19).  These included the 
expression  of murine  DC-restricted  cell  surface immuno- 
phenotypic markers (27).  The ceils did not, however, con- 
form to the stereotypic features dassicaUy associated with ma- A 
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Figure  5.  Allostimulatory activity of )'-irradiated,  GM-CSF plus  IL- 
4-stimulated, bone marrow-derived DC determined using naive B10 (A) 
or C3H (B) splenic T cells as responders.  The cells were harvested from 
10-d cultures  and set up with 2  x  103 responder  T  cells. Syngeneic or 
aUogeneic  cells, mixtures of syngeneic and allogeneic cells, or cells  propagated 
from the bone marrow of OLTx recipients  (14 d after  transplant)  were 
tested  as stimulators.  Cultures were maintained  for 72 h;  [3H]TdR was 
added 18 h before harvesting.  The results  are expressed as mean cpm  _+ 
1 SD and are representative of three separate experiments.  50  x  103 fresh 
syngeneic  spleen cells (C3H or B10) failed to induce a MLR. 
ture murine DC (11, 15, 25). Thus, they were MHC Class 
II -/dim in contrast to MHC class II  b~ight spleen-derived DC 
propagated  under similar conditions,  and  they were poor 
stimulators of allogeneic T  cells. They thus resembled im- 
munologically immature DC (15, 28). When, however, these 
cells were exposed to the liver microenvironmental extracel- 
lular matrix protein type I collagen for 3-4  d  in the con- 
tinued presence of GM-CSF, they assumed more mature DC 
characteristics. These included strong cell surface MHC class 
II expression, loss  of phagocytic ability, and acquisition of 
potent aUostimulatory activity (19). In addition, we observed 
that 1 to at least 60 d after these immature DC progenitors 
were injected locally or systemically into MHC and non-MHC 
disparate recipients, donor cells that were MHC class II  bright 
could be detected readily within T  cell areas  of the host's 
lymphoid tissues (20). 
Figure 6.  Detection of the donor Y chromosome in freshly isolated 
(day 0) and 10-d cultured bone marrow cells from female (C3H) recipients 
of male (B10) livers or hearts. The animals were killed 14 d or 8 d, respec- 
tively, after transplantation.  In this strain combination, liver allografts are 
accepted spontaneously,  whereas heart  grafts  are rejected with a median 
survival time of 8 d.  Growth of donor-derived  cells is again evident  in 
the DC cultures  propagated  from the bone  marrow  of liver allograft 
recipients, whereas  there is little evidence of survival of male cells in the 
cultures from heart graft recipients. The results are representative of three 
separate experiments.  The technical details are as described in Materials 
and  Methods. 
These observations suggested, amongst other implications, 
a mechanism for liver DC precursor expansion and a possible 
basis for the establishment and perpetuation of donor-derived 
cell microchimerism after OLTx. The findings have now been 
extended to the context of whole organ transplantation.  In 
the present study, an MHC class I- and II-disparate mouse 
strain combination (B10 -~ C3H)  that  accepts  liver grafts 
spontaneously was used to determine whether liver-derived 
DC progenitors could be propagated from recipient lymphoid 
tissue.  To confirm the presence of donor-derived cells,  we 
first examined with flow cytometry the frequency of donor 
and recipient MHC class I + leukocytes in freshly isolated cell 
suspensions from the bone marrow, spleen, thymus, and liver 
14 d  after OLTx.  As anticipated, donor class I §  cells were 
rare (~<1%) in the freshly isolated cell populations isolated 
from recipient primary and secondary lymphoid tissues.  A 
higher incidence of donor class  I +  NPC  (5-9%)  was  de- 
tected in the liver aUograft itself. When, however, cells were 
harvested from recipient bone marrow 14 d after OLTx and 
then cultured for 10 d in GM-CSF, a significant proportion 
of the developing DC exhibited donor phenotype. The same 
phenomenon was observed with cells propagated from the 
spleen, although the apparent growth of donor-derived DC 
was less striking. The expression of MHC class II on these 
cells could most accurately be studied after immunochemical 
staining of cytospin preparations. Similar to the class I results, 
donor class II + cells were readily detected in the GM-CSF- 
stimulated cultures from bone marrow and spleen, both of 
which are hemopoietic tissues.  In contrast, although donor 
class I §  and II § cells were also  detected in freshly isolated 
thymocyte  preparations,  it proved consistently difficult to dem- 
onstrate ex vivo growth of  DC progenitors from the thymuses 
of liver-allografted mice. 
Definitive evidence for the growth of donor liver-derived 
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tained by detection of the presence of the (donor) Y chromo- 
some by PCR. amplification and Southern blotting.  These 
revealed a level of chimerism in the GM-CSF-stimulated cul- 
tures of ,,o1-10%  (Fig.  3).  Definitive evidence that donor- 
positive cells were DC was obtained by demonstration of the 
Y chromosome (Fig.  4) and allostimulatory activity for re- 
cipient strain naive T cells (Fig. 5 B) in highly purified NLDC 
145 + cell populations. In marked contrast to these findings, 
donor-derived cells could not be propagated from the bone 
marrow, spleen, or thymus of unmodified cardiac allograft 
recipients rejecting their transplants at 8 d. Although donor- 
derived cells were detected in the freshly isolated bone marrow, 
these cells clearly did not comprise sufficient numbers of GM- 
CSF-responsive cells to allow perpetuation of donor signal 
for 10 d in culture. An implication of these observations is 
that acceptance of an organ allograft may be dependent on 
sustained chimerism comprising sufficient numbers of the ap- 
propriate donor-derived progenitor cell population(s). 
Our observations appear to explain the persistence of low- 
level chimerism that does not require host immunosuppres- 
sion in the B10 "~ C3H liver transplant model. They are also 
consistent with the adult liver containing comparatively large 
numbers of (potential migratory) hemopoietic cells (29), in- 
cluding DC progenitors with the capacity to propagate ex 
vivo in response to appropriate growth factors. The observa- 
tion that organ transplantation permits the growth of donor 
as well as recipient progenitor DC is congruent with the par- 
adigm of bidirectional immune reactivity, which, we have 
suggested, may explain whole-organ graft acceptance and ac- 
quired tolerance in a different way than previously envisioned 
(1, 5, 6, 8, 30). We postulate that the peripheral tissues and 
the graft itself become repositories of precursor cells of my- 
eloid and probably other lineages, or perhaps even of pluripo- 
tent stem cells. The presence of these precursor cells can poten- 
tially be  identified,  as  in  this  study, by their patterns  of 
differentiation under controlled culture conditions. 
The functional role of the precursors of chimeric DC is 
currently being investigated. Others have demonstrated a veto 
function for either subpopulations of murine DC (31) or puta- 
tive immature DC in primate allogeneic bone marrow (32, 
33). Moreover, there is strong evidence that the reduction 
of MHC class I-specific cytotoxic responses in mice injected 
with allogeneic donor lymphoid cells is a function of donor- 
deletional APC that inactivate class I-reactive CTL precursors 
that recognize them (34). The presence of donor-derived DC 
for up to I  yr in rodents tolerant to their allografts (5, 6) 
and for many years after OLTx in humans (2) has been demon- 
strated. Moreover, using techniques described in the present 
study, we have preliminary evidence that donor-derived cells 
can be propagated from the bone marrow of unmodified mu- 
rine liver allograft recipients up to 5 mo after transplant (our 
unpublished observations).  The magnitude, tissue-specific site 
dependency, replicative capacity, and maturational stage of 
chimeric DC (including cell surface expression of key T ceU- 
costimulatory molecules [35, 36]) that may be necessary to 
mediate postulated tolerizing effects of these cells have not 
been established. 
Our failure to propagate chimeric DC progenitors from 
the thymus is of particular interest. Previous reports have 
shown that either intrathymic (37) or intravenous (38) donor 
bone marrow cell infusion in antilymphocyte serum/anti- 
thymocyte globulin-treated mice results in only a compara- 
tively low level of thymic chimerism that can no longer be 
detected after 3 wk. Indeed, permanent cardiac graft survival 
in mice is maintained despite the apparent absence of donor 
bone marrow cell-derived chimerism in the thymus (37). 
Moreover, the thymus is not required for the induction of 
liver-induced transplantation tolerance (39). Thus, chimerism 
in the periphery may be more important in maintaining a 
tolerant state (40--42). Conceivably, the recipient bone marrow 
may provide a repository of donor-derived DC progenitors 
with the potential to migrate to key peripheral sites.  The 
unique observations in this study provide an opportunity for 
elucidation of the role of donor-derived cells in the induc- 
tion and maintenance of donor-specific unresponsiveness  after 
organ transplantation. 
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